NASDAQ-LISTED North American pharmaceutical-grade medicinal cannabis producer Tilray has announced it has successfully exported medical cannabis from Canada to Australia to distribute to critically ill children.
Tilray said it will distribute its CBD 100 product to three hospitals in the state of Victoria via its wholly-owned subsidiary Tilray Australia New Zealand Pty Ltd.
The products are being supplied to Royal Children's Hospital, Monash Children's Hospital and Austin Health with support from the Government of Victoria's Department of Health and Human Services, Victoria (DHHS), where they will be distributed to children suffering from intractable epilepsy.
The company first exported medicinal cannabis to Victoria 18 months ago (PD 06 Mar 2017) for 29 critically ill children through a compassionate access scheme.
According to a Victorian Government update, in less than one year the scheme "has already helped children see a reduction in seizures and has significantly improved their quality of life."
Tilray CBD 100 is an oral solution of concentrated cannabinoid extract with a target concentration of 100mg/ml CBD in a 25ml vial.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Sep 18
